Astarte Medical is a clinical intelligence company dedicated to improving health outcomes for high-risk infants, particularly those in the neonatal intensive care unit (NICU). They focus on precision nutrition, utilizing data analytics, machine learning, and digital tools to support feeding protocols, monitor gut health, and optimize infant development. Their flagship platform, NICUtrition®, aims to standardize care and provide actionable insights to clinicians, ultimately reducing complications like necrotizing enterocolitis (NEC) and promoting healthier growth trajectories for vulnerable preterm infants. From an end-user perspective, Astarte Medical provides critical tools and data that empower healthcare providers to make more informed, personalized nutritional decisions for their smallest patients, leading to better short-term and long-term health.
The headquarters serves as the central hub for Astarte Medical's research and development, product innovation, strategic planning, commercial operations, and administrative functions.
While specific architectural details are not widely publicized, the headquarters likely features modern office and collaborative workspaces conducive to a technology-focused company, potentially including areas for data analysis and software development.
The work culture at Astarte Medical's headquarters is likely mission-driven, innovative, and collaborative, with a strong emphasis on scientific rigor and improving infant health. Employees are probably passionate about making a tangible difference in neonatal care.
Its location in the greater Philadelphia area provides Astarte Medical with access to a rich ecosystem of leading children's hospitals, research institutions, and a skilled talent pool in medicine, data science, and biotechnology, fostering innovation and partnerships.
Astarte Medical's primary operational focus is currently within the United States, where they are working to implement their precision nutrition solutions in NICUs. While their technology and research address a global need in neonatal care, their direct commercial presence and support functions are predominantly U.S.-based. The potential for international expansion exists as their solutions mature and gain wider adoption.
10 N. Main Street
Yardley
PA
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Astarte Medical' leadership includes:
Astarte Medical has been backed by several prominent investors over the years, including:
Based on publicly available information, there have been no major executive new hires or exits publicly announced at Astarte Medical in the last 12 months (approximately May 2023 - May 2024). The existing leadership team appears stable.
Discover the tools Astarte Medical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Astarte Medical likely utilizes standard professional email address formats common in the technology and healthcare industries. While the exact structure can vary, a common pattern is combining an employee's first initial and last name, or first name and last name separated by a dot, with the company's domain.
[first_initial][last]@astartedx.com
Format
jdoe@astartedx.com
Example
85%
Success rate
Business Wire (via astartedx.com) • October 10, 2023
Astarte Medical announced it was awarded U.S. Patent No. 11,756,618 for its innovative methods to standardize enteral feeding protocols in the neonatal intensive care unit (NICU). This patent protects the company's approach to improving nutritional management for premature infants through its NICUtrition platform....more
Business Wire (via astartedx.com) • May 10, 2023
Research published in the Journal of Perinatology demonstrated the significant impact of Astarte Medical's NICUtrition® analytics solution on improving growth outcomes in preterm infants. The study highlighted the platform's ability to support clinical decision-making and optimize nutritional intake....more
Business Wire (via astartedx.com) • January 10, 2023
Astarte Medical received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its NICUtrition® GI Health Score. This designation is intended to expedite the development and review of medical devices that offer more effective treatment or diagnosis of life-threatening or irreversibly debilitating diseases or conditions....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Astarte Medical, are just a search away.